Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 381

1.

Very low calorie diet (VLCD): a useful alternative in the treatment of the obese NIDDM patient.

Capstick F, Brooks BA, Burns CM, Zilkens RR, Steinbeck KS, Yue DK.

Diabetes Res Clin Pract. 1997 May;36(2):105-11.

PMID:
9229194
3.

Latin-American trial of orlistat for weight loss and improvement in glycaemic profile in obese diabetic patients.

Halpern A, Mancini MC, Suplicy H, Zanella MT, Repetto G, Gross J, Jadzinsky M, Barranco J, Aschner P, Ramirez L, Matos AG.

Diabetes Obes Metab. 2003 May;5(3):180-8.

PMID:
12681025
4.

The effect of short periods of caloric restriction on weight loss and glycemic control in type 2 diabetes.

Williams KV, Mullen ML, Kelley DE, Wing RR.

Diabetes Care. 1998 Jan;21(1):2-8.

PMID:
9538962
5.

The effect of orlistat-induced weight loss, without concomitant hypocaloric diet, on cardiovascular risk factors and insulin sensitivity in young obese Chinese subjects with or without type 2 diabetes.

Tong PC, Lee ZS, Sea MM, Chow CC, Ko GT, Chan WB, So WY, Ma RC, Ozaki R, Woo J, Cockram CS, Chan JC.

Arch Intern Med. 2002 Nov 25;162(21):2428-35.

PMID:
12437401
6.
7.

Weight loss with sibutramine improves glycaemic control and other metabolic parameters in obese patients with type 2 diabetes mellitus.

Fujioka K, Seaton TB, Rowe E, Jelinek CA, Raskin P, Lebovitz HE, Weinstein SP; Sibutramine/Diabetes Clinical Study Group.

Diabetes Obes Metab. 2000 Jun;2(3):175-87.

PMID:
11220553
9.

Metabolic consequences of very-low-calorie diet therapy in obese non-insulin-dependent diabetic and nondiabetic subjects.

Henry RR, Wiest-Kent TA, Scheaffer L, Kolterman OG, Olefsky JM.

Diabetes. 1986 Feb;35(2):155-64.

PMID:
3510922
10.
11.

Potentiation of effects of weight loss by monounsaturated fatty acids in obese NIDDM patients.

Low CC, Grossman EB, Gumbiner B.

Diabetes. 1996 May;45(5):569-75.

PMID:
8621005
12.

Effect of mazindol on body weight and insulin sensitivity in severely obese patients after a very-low-calorie diet therapy.

Nishikawa T, Iizuka T, Omura M, Kuramoto N, Miki T, Ito H, Chiba S.

Endocr J. 1996 Dec;43(6):671-7.

13.
14.

Benefits and limitations of very-low-calorie diet therapy in obese NIDDM.

Henry RR, Gumbiner B.

Diabetes Care. 1991 Sep;14(9):802-23. Review.

PMID:
1959474
15.

Effect of a low-carbohydrate diet on appetite, blood glucose levels, and insulin resistance in obese patients with type 2 diabetes.

Boden G, Sargrad K, Homko C, Mozzoli M, Stein TP.

Ann Intern Med. 2005 Mar 15;142(6):403-11.

PMID:
15767618
17.

Differences in glycaemic status do not predict weight loss in response to hypocaloric diets in obese patients.

de Luis DA, Aller R, Izaola O, Gonzalez Sagrado M, Conde R.

Clin Nutr. 2006 Feb;25(1):117-22. Epub 2005 Nov 8.

PMID:
16278036
18.

Early and long-term effects of acute caloric deprivation in obese diabetic patients.

Bauman WA, Schwartz E, Rose HG, Eisenstein HN, Johnson DW.

Am J Med. 1988 Jul;85(1):38-46.

PMID:
3291612
19.

Daily walking combined with diet therapy is a useful means for obese NIDDM patients not only to reduce body weight but also to improve insulin sensitivity.

Yamanouchi K, Shinozaki T, Chikada K, Nishikawa T, Ito K, Shimizu S, Ozawa N, Suzuki Y, Maeno H, Kato K, et al.

Diabetes Care. 1995 Jun;18(6):775-8.

PMID:
7555502
20.

Past and current obesity in Koreans with non-insulin-dependent diabetes mellitus.

Park JY, Lee KU, Kim CH, Kim HK, Hong SK, Park KS, Lee HK, Min HK.

Diabetes Res Clin Pract. 1997 Feb;35(1):49-56.

PMID:
9113475

Supplemental Content

Support Center